Casimersen
An antisense oligonucleotide that targets a specific sequence in pre-messenger RNA to promote skipping of exon 45 of the dystrophin gene, allowing production of a truncated but partially functional dystrophin protein. It is approved for the treatment of Duchenne muscular dystrophy in patients with mutations amenable to this particular exon skipping. Treatment may slow disease progression in eligible patients.
Wirkmechanismus
Binds to complementary mRNA sequences through Watson-Crick base pairing, modulating gene expression by promoting mRNA degradation via RNase H or altering pre-mRNA splicing.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Binds to complementary mRNA sequences through Watson-Crick base pairing, modulating gene expression by promoting mRNA degradation via RNase H or altering pre-mRNA splicing.
HBD / HBA
- / -
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Häufig gestellte Fragen
An antisense oligonucleotide that targets a specific sequence in pre-messenger RNA to promote skipping of exon 45 of the dystrophin gene, allowing production of a truncated but partially functional dystrophin protein. It is approved for the treatment of Duchenne muscular dystrophy in patients with mutations amenable to this particular exon skipping. Treatment may slow disease progression in eligible patients.
Binds to complementary mRNA sequences through Watson-Crick base pairing, modulating gene expression by promoting mRNA degradation via RNase H or altering pre-mRNA splicing.
Yes, Casimersen is an approved drug. It has reached clinical phase 4. It is classified as a Oligonucleotide.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL4297566. Open-access bioactivity database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.
Medizinischer Haftungsausschluss
This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="casimersen"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/casimersen/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/casimersen/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/casimersen/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="casimersen"></drugfyi-drug>